Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir

gan Ouwerkerk-Mahadevan, Sivi, Snoeys, Jan, Peeters, Monika, Beumont-Mauviel, Maria, Simion, Alexandru
Cyhoeddwyd yn Clin Pharmacokinet (2015)

Evaluation of the Pharmacokinetics and Renal Excretion of Simeprevir in Subjects with Renal Impairment

gan Ouwerkerk-Mahadevan, Sivi, Beumont-Mauviel, Maria, Mortier, Steven, Peeters, Monika, Verloes, Rene, Truyers, Carla, Mannens, Geert, Wynant, Inneke, Simion, Alexandru
Cyhoeddwyd yn Drugs R D (2015)

Telaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysis

gan Montes, Marisa, Nelson, Mark, Marie Girard, Pierre, Sasadeusz, Joe, Horban, Andrzej, Grinsztejn, Beatriz, Zakharova, Natalia, Rivero, Antonio, Lathouwers, Erkki, Janssen, Katrien, Ouwerkerk-Mahadevan, Sivi, Witek, James
Cyhoeddwyd yn J Int AIDS Soc (2014)

Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications

gan Marra, Fiona, Höner zu Siederdissen, Christoph, Khoo, Saye, Back, David, Schlag, Michael, Ouwerkerk‐Mahadevan, Sivi, Bicer, Ceyhun, Lonjon‐Domanec, Isabelle, Jessner, Wolfgang, Beumont‐Mauviel, Maria, Kalmeijer, Ronald, Cornberg, Markus
Cyhoeddwyd yn Br J Clin Pharmacol (2018)

Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbu...

gan Bourgeois, Stefan, Horsmans, Yves, Nevens, Frederik, van Vlierberghe, Hans, Moreno, Christophe, Beumont, Maria, Vijgen, Leen, van Eygen, Veerle, Luo, Donghan, Hillewaert, Vera, Van Remoortere, Pieter, van de Logt, Jolanda, Ouwerkerk-Mahadevan, Sivi
Cyhoeddwyd yn Antimicrob Agents Chemother (2017)